The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
| Factor | Score | Distribution | Value | Avg | Verdict |
|---|---|---|---|---|---|
Valuation | 37 | — | 20.1x | Near average | |
Growth | 19 | — | 5.6% | Below average | |
Quality | 5 | -851.5% | 7.6% | Below average | |
Safety | 34 | 0.1x | 0.4x | Near average | |
Capital Return | 41 | — | 2.19% | Near average | |
Momentum | — | — | — | No data | |
Sentiment | — | — | — | No data |
Skye Bioscience, Inc. is a publicly traded stock representing ownership in the company, giving holders rights to dividends and voting.
You can buy Skye Bioscience, Inc. shares through a licensed brokerage. Research the company's financials before investing.
Key metrics include Price-to-Earnings (P/E) ratio, Return on Equity (ROE), revenue growth, and net profit margin.
Dividend policies vary by company. Check the dividends section on the stock page for the payout history.
Risks include market volatility, sector-specific risks, regulatory changes, and company financial performance. Diversification helps reduce risk.
AI analysis from the earnings call, financials and news
This section combines price targets, revision history, analyst coverage changes, and an AI summary of what changed on the Street.
The analyst forecast analysis for SKYE shows a state of quantitative stability in price targets alongside a sharp variance in estimates (Dispersion). The average price target has stabilized at 12 dollars over the past thirty days without any revisions from the three analysts covering the stock, indicating a wait for new catalysts. However, the large gap between the low estimate (2 dollars) and the high estimate (21 dollars) reflects a state of high uncertainty regarding the stock's fair value.
Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.